Aurobindo Pharma Limited — ≥1% Shareholders
Every non-promoter shareholder owning 1% or more of Aurobindo Pharma Limited, parsed from the latest quarterly Shareholding Pattern filing. Curated holders link to a tracked profile; mystery holders are flagged.
1 curated
12 mystery
Quarter: Mar 2026
Institutional intelligence for Aurobindo Pharma Limited
Cross-view mutual fund activity and super-investor shareholding · Mar 2026 SHP.
Tracked super investors holding ≥1%
| Holder | Type | % of company | Shares | Value (₹ Cr) |
|---|---|---|---|---|
| RPR SONS ADVISORS PRIVATE LIMITED, MRS.P.SUNEELA RANI (JOINTLY HOLDING) | dii | 33.50% | 19,45,61,357 | ₹25.38k Cr |
| QUANT MUTUAL FUND - QUANT ARBITRAGE FUND | dii | 4.98% | 2,89,18,769 | ₹3.77k Cr |
| K NITYANANDA REDDY | individual | 4.37% | 2,53,59,572 | ₹3.31k Cr |
| KIRTHI REDDY KAMBAM | individual | 3.45% | 2,00,62,852 | ₹2.62k Cr |
| HDFC TRUSTEE COMPANY LTD. A/C HDFC BALANCED ADVANT | dii | 3.20% | 1,85,85,812 | ₹2.42k Cr |
| VENKATA RAMPRASAD REDDY PENAKA | fii | 3.07% | 1,78,33,646 | ₹2.33k Cr |
| LIC | dii | 2.93% | 1,69,90,585 | ₹2.22k Cr |
| AXIS CLINICALS LIMITED, TRIDENT CHEMPHAR LIMITED, RPR SONS ADVISORS PVT.LTD. (JOINTLY HOLDING) | dii | 2.85% | 1,65,72,131 | ₹2.16k Cr |
| M SIVAKUMARAN | individual | 2.47% | 1,43,57,432 | ₹1.87k Cr |
| NPS TRUST- A/C ICICI PRUDENTIAL PENSION FUND SCHEM | dii | 2.34% | 1,35,99,080 | ₹1.77k Cr |
| ICICI PRUDENTIAL INDIA OPPORTUNITIES FUND | dii | 2.09% | 1,21,24,095 | ₹1.58k Cr |
| SBI BALANCED ADVANTAGE FUND | dii | 1.87% | 1,08,52,396 | ₹1.42k Cr |
| KAMBAM SPOORTHI | individual | 1.19% | 69,39,173 | ₹905.1 Cr |
Shareholding data sourced from NSE/BSE regulatory filings. Not investment advice. See our disclaimer and methodology.